Stockholders' Equity - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended	1 Months Ended		12 Months Ended	1 Months Ended						1 Months Ended		0 Months Ended	1 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	May 31, 2013 Outside Board Member [Member] Directors	Dec. 31, 2013 Eleven Employees [Member]	Dec. 31, 2013 Eleven Employees [Member] Employees	Feb. 28, 2013 Five Employees [Member] Employees	Feb. 28, 2013 Five Employees [Member] Other Than Performance Shares [Member]	Feb. 28, 2013 Five Employees [Member] Performance Shares [Member]	Feb. 28, 2013 Seven Employees and Five Outside Board Members [Member] Directors Employees	Feb. 28, 2013 Seven Employees and Five Outside Board Members [Member] Performance Shares [Member]	Jan. 31, 2014 Jonathan J. Corp [Member]	Jan. 31, 2014 Jonathan J. Corp [Member] Common Stock [Member]	Nov. 30, 2013 Oppenheimer & Co., Inc [Member] Common Stock [Member]	Jan. 24, 2014 Clarence E. Smith [Member]	Jan. 31, 2014 Clarence E. Smith [Member]	Nov. 30, 2013 Clarence E. Smith [Member]
Disclosure Stockholders Equity Additional Information Detail [Line Items]
Common stock options granted, exercise price				$ 3.00			$ 2.50			$ 2.50		$ 0.65
Common stock granted under the long term incentive bonus program							42,000	36,000	6,000				25,000	37,500
Exercised price																$ 1.50	$ 1.50
Number of options exercised	163,331		30,500												138,331	138,331
Beneficial ownership percentage																5.00%	5.00%
Common Stock Granted under Long term incentive plan			446,000	100,000	9,000					346,000	12,000
Shares vested using fair market value					9,000	9,000
Number of employees						11	5			7
Total share-based compensation expense	$ 198,541	$ 310,062				$ 25,650
Share-based compensation, option vesting period				3 years				3 years	3 years	3 years
Compensation expense amortization period							3 years
Number of Directors				1						5
Expected term				5 years						5 years